• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,563.92 -1,470.50
( -1.93%)
Global Indices
Nasdaq
46,702.98 -735.30
(-1.55%)
Dow Jones
6,694.68 -102.12
(-1.50%)
Hang Seng
53,838.16 -614.80
(-1.13%)
Nikkei 225
10,300.41 -53.36
(-0.52%)
Forex
USD-INR
91.92 0.02
(0.02%)
EUR-INR
106.58 -0.28
(-0.27%)
GBP-INR
123.39 -0.12
(-0.10%)
JPY-INR
0.58 0.00
(-0.46%)

EQUITY - MARKET SCREENER

Vivimed Labs Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532660
INE526G01021
0.9167078
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VIVIMEDLAB
0
57.79
EPS(TTM)
Face Value()
Div & Yield %
0
2
0
 
( Cr)
ParticularsSep 2025 ( Cr)Jun 2025 ( Cr)Mar 2025 ( Cr)
Gross Sales18.6617.9422.58
Other Operating Income0.000.000.00
Other Income 0.160.364.15
Total Income18.8218.3026.73
Total Expenditure 19.9818.4825.06
PBIDT-1.16-0.181.67
Interest 1.600.521.48
PBDT-2.76-0.700.20
Depreciation4.684.804.61
Tax0.000.000.00
Fringe Benefit Tax0.000.000.00
Deferred Tax0.000.000.00
Reported Profit After Tax-7.45-5.50-4.42
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item-7.45-5.50-4.42
EPS (Unit Curr.)-0.90-0.66-0.53
EPS (Adj) (Unit Curr.)-0.90-0.66-0.53
Calculated EPS (Unit Curr.)-0.90-0.66-0.53
Calculated EPS (Adj) (Unit Curr.)-0.90-0.66-0.53
Calculated EPS (Ann.) (Unit Curr.)-3.59-2.65-2.13
Calculated EPS (Adj) (Ann.) (Unit Curr.)-3.59-2.65-2.13
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity16.5816.5816.58
Reserve & Surplus0.000.000.00
Face Value2.002.002.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)-6.22-1.007.40
PBDTM(%)-14.79-3.900.89
PATM(%)-39.92-30.66-19.57